Samuel Arbesman

Scientist in Residence at Lux Capital · United States

Invests in AI

Samuel Arbesman's investor profile lists AI alongside MedTech & Medical Devices, Digital Health & HealthTech and AR/VR & Metaverse, at seed, Series A, Series B and late-stage venture. The record holds 78 deals, among them Auris Health, Workit Health and OpenSpace.

Email Investor

Email Investor

Credits to line up before a seed round

Samuel Arbesman backs companies at seed, Series A and Series B. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Auris Health
  • Workit Health
  • OpenSpace
  • Science 37
  • Statespace
  • Mos
  • Roam Research
  • Orbital Insight
  • Strangeworks
  • Kallyope
  • Hugging Face
  • SteadyMD
  • Saildrone
  • Avail Medsystems
  • Lightform
  • Nozomi Networks
  • ZEDEDA
  • Chronosphere
  • Rosebud AI
  • neo.tax
  • Fiddler AI
  • Echodyne
  • Anduril Industries
  • SkySelect
  • Flex Logix Technologies
  • Latch
  • Mahana Therapeutics
  • Elektra Labs
  • H1
  • Anchorage
  • Primer
  • Mythic
  • Vium
  • Evolv Technology
  • Vesta Healthcare
  • Somatic Labs
  • Cape Analytics
  • Visla Labs
  • Paceline
  • Survios
  • CTRL-labs
  • Ahana
  • Shiru
  • Pager
  • Onaroll
  • Runway
  • Thrive Earlier Detection
  • Ripcord
  • Kyruus
  • Benchling

Showing 50 of 78 deals on record.

Investment focus

Backs startups in
Artificial Intelligence, MedTech & Medical Devices, Digital Health & HealthTech, AR/VR & Metaverse, SaaS & Enterprise, Space & Aerospace and 3 more
Rounds
Seed, Series A, Series B, Late-stage venture
Profile
Venture investor
Deals on record
78
Based in
United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Samuel Arbesman invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Samuel Arbesman's investor profile, together with MedTech & Medical Devices, Digital Health & HealthTech and AR/VR & Metaverse. The stages on record are seed, Series A, Series B and late-stage venture.
Which companies has Samuel Arbesman backed?
The record lists 78 deals, including Auris Health, Workit Health, OpenSpace, Science 37 and Statespace. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Samuel Arbesman?
For a company raising a seed round, AI Perks lists credits such as Algolia (up to $10,000), Beefree SDK (up to $10,000), Aiven (up to $100,000) and Deepgram (up to $100,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor